This is a surgery where a healthy heart is moved from one person to another. It's done when the person's own heart is too damaged to work properly.
Every report comes from a Lived member, sent anonymously.
Have you had Heart Transplantation for Heart Failure?
A heart transplant is surgery that removes a failing heart and replaces it with a healthy heart from a donor who has died. It is reserved for end-stage heart failure, meaning the heart is so damaged or weak that it can no longer pump enough blood for the body, and medicines, devices and other surgery are no longer enough. The underlying cause is often cardiomyopathy (disease of the heart muscle), severe damage after heart attacks, valve disease or a heart defect present from birth that cannot be repaired. Life-threatening heart rhythm problems that resist other treatment are a less common reason. Children and adults can both receive transplants, and many programs consider adults up to about age 70, sometimes older. Because donor hearts are scarce, candidates must meet strict criteria. A transplant team looks for a good chance of surviving the operation and living better afterward. Active infection, recent cancer, serious disease of other organs such as the kidneys, lungs or liver, ongoing smoking or substance use, and difficulty keeping up with lifelong medicines and frequent visits can each make a transplant unsafe or unlikely to succeed.
The process starts with referral to a transplant center and a detailed evaluation over several weeks or months. Testing usually includes blood work, kidney and liver function, screening for infection and cancer, imaging of the heart such as an echocardiogram (an ultrasound of the heart) and cardiac catheterization, which measures pressures inside the heart and lungs through a thin tube. Blood and tissue typing help match a donor heart and lower the chance of rejection. The team also asks about home support, finances and the ability to manage the care that follows, and vaccinations need to be brought up to date before the immune system is suppressed. Accepted candidates join a national waiting list run in the US by the United Network for Organ Sharing. For adults, priority depends mainly on how sick the person is, along with blood type and body size, rather than how long they have waited. Some people receive a heart within days; others wait months or longer, and there is no guarantee one will become available. Many people waiting are in the hospital, and many need a bridge treatment to keep blood flowing, most often a ventricular assist device (VAD), a mechanical pump attached to the heart. It is worth asking centers about how many transplants they perform, support groups, and help with travel and housing.
Heart transplant surgery is done under general anesthesia, so the person is fully asleep, and a ventilator breathes for them. The surgeon opens the chest through the breastbone and connects a heart-lung bypass machine, which pumps and oxygenates the blood while the heart is stopped. The diseased heart is removed and the donor heart is stitched to the major blood vessels. Once blood flows through it, the new heart takes over, sometimes with temporary electrical pacing to help it beat steadily, and the bypass machine is disconnected. Tubes are left in the chest for several days to drain fluid and air. The operation usually takes about 4 to 10 hours.
Most people spend the first day or two in intensive care and go home after about one to three weeks, depending on how sick they were beforehand and how recovery goes. The breastbone incision takes about six to eight weeks to heal, and full recovery takes several months. Many centers ask people to stay near the hospital for about the first three months, and cardiac rehabilitation, a supervised exercise and education program, helps rebuild strength. The immune system treats the new heart as foreign, so anti-rejection medicines (immunosuppressants) must be taken every day for the rest of a person's life. Missing doses can trigger rejection, and the team adjusts these medicines over time based on blood levels and side effects. Rejection often causes no symptoms at first, so heart muscle biopsies, in which a small tissue sample is taken through a vein, are done frequently in the first 6 to 12 months and less often later. Blood tests, echocardiograms and regular visits continue for years, along with guidance on vaccines, dental care and cancer screening. Most recipients return to their usual daily activities, though fewer than a third return to work, for many different reasons. Feeling grateful, overwhelmed or low after transplant is common, and support groups and counseling can help. When rejection does cause symptoms, they can look like a return of heart failure: new tiredness or weakness, mild new shortness of breath, swelling of the feet, hands or ankles, sudden weight gain or less urine than usual. Infection can show up as fever or chills, or as drainage, redness or warmth at the incision. Call the transplant team the same day for any of these, for a breastbone that feels as if it is moving or clicking, or for a new general feeling of being unwell. Infections can move quickly when immunity is suppressed, and the team needs to decide whether tests are needed. Call 911 for shortness of breath that is severe or getting worse quickly, a racing heartbeat with dizziness, or fainting.
Heart transplantation is major surgery in people who are often very ill beforehand. Early risks include bleeding, infection, blood clots, stroke, heart rhythm problems, delirium and graft failure, meaning the new heart does not work well. Graft failure is most dangerous in the first month and serious infection in the first year, which is why monitoring and infection precautions are most intensive early on. Over the long term, the main concerns are rejection and the effects of the medicines that prevent it. Suppressing the immune system raises the risk of infections and some cancers. The same medicines can damage the kidneys and contribute to diabetes, high blood pressure, high cholesterol and bone thinning, so these are watched and treated. Cardiac allograft vasculopathy, a gradual narrowing of the new heart's arteries driven by the immune system, is a common reason for later problems and is checked with periodic testing. Outcomes have improved steadily. In North America, about 91% of recipients are alive one year after surgery, and half are still alive about 14 years later; some live more than 20 years. Individual prospects depend on age, other health problems and complications, and the transplant team can give a more personal estimate.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Heart Transplantation, what to expect, or ask the community a question.